Molecular Partners Ag (MOLN) Change in Account Payables (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Change in Account Payables of $192.83 for Q1 2026, down 75.09% year-on-year from $774.13 in Q1 2025, and down 99.76% on a QoQ basis from $80794.3 in Q4 2025.

Molecular Partners Ag (MOLN) Change in Account Payables (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Change in Account Payables for 7 consecutive years, with $192.83 the latest figure, recorded in Q1 2026.

  • Quarterly Change in Account Payables fell 75.09% year-over-year to $192.83 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69236.3 (down 86.74% YoY) and the FY2025 annual result came in at $81326.0, down 86.4% from the prior year.
  • Change in Account Payables retreated to $192.83 in Q1 2026 per MOLN's latest filing, from $80794.3 in the prior quarter.
  • Over the last five years, Change in Account Payables for MOLN reached as high as $1.9 million in Q3 2022 and fell as low as -$5.5 million in Q4 2022.
  • A 5-year average of -$345940.2 and a median of $773.03 in 2023 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2022 — Change in Account Payables slumped 407.97% — and 2024, when it soared 174.63%.
  • Year by year, Change in Account Payables stood at -$5.5 million in 2022, then soared by 83.47% to -$915352.1 in 2023, then surged by 165.22% to $596955.4 in 2024, then sank by 86.47% to $80794.3 in 2025, then slumped by 99.76% to $192.83 in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered $192.83, $80794.3, and -$338248.4 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -42.19 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.52 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.86 Mn
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - 192.83

Historic Data

Download Data
DateValue
Mar 31, 2026 192.83
Mar 31, 2026 192.83
Dec 31, 2025 80,794.29
Dec 31, 2025 80,794.29
Sep 30, 2025 -338,248.38
Sep 30, 2025 -338,248.38
Jun 30, 2025 326,497.56
Jun 30, 2025 326,497.56
Mar 31, 2025 774.13
Mar 31, 2025 774.13
Dec 31, 2024 596,955.43
Dec 31, 2024 596,955.43
Sep 30, 2024 -1.78 Mn
Sep 30, 2024 -1.78 Mn
Jun 30, 2024 1.70 Mn
Jun 30, 2024 1.70 Mn
Mar 31, 2024 2,122.95
Mar 31, 2024 2,122.95
Dec 31, 2023 -915,352.08
Dec 31, 2023 -915,352.08